Home/Filings/4/0001104659-15-075314
4//SEC Filing

EPIRUS Biopharmaceuticals, Inc. 4

Accession 0001104659-15-075314

CIK 0001135906operating

Filed

Nov 2, 7:00 PM ET

Accepted

Nov 3, 4:33 PM ET

Size

14.3 KB

Accession

0001104659-15-075314

Insider Transaction Report

Form 4
Period: 2015-11-02
Shea Thomas A.
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2015-11-02+56,84256,842 total
    Exercise: $5.55Exp: 2025-11-02Common Stock (56,842 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to this option shall vest on the one year anniversary of the grant date and the remaining shares shall vest in substantially equal monthly installments over the next three (3) years, provided the Reporting Person remains continuously employed by the Issuer through each vesting date.

Issuer

EPIRUS Biopharmaceuticals, Inc.

CIK 0001135906

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001135906

Filing Metadata

Form type
4
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 4:33 PM ET
Size
14.3 KB